Pathological classification and molecular genetics of meningiomas.
about
Mast cells in meningiomas and brain inflammationLoss of the protein-tyrosine phosphatase DEP-1/PTPRJ drives meningioma cell motilityMolecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingBrain tumors: Special characters for research and bankingTranscriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Common variation at 10p12.31 near MLLT10 influences meningioma risk.Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior.Pediatric meningioma: current approaches and future direction.Proteomic data in meningiomas: post-proteomic analysis can reveal novel pathophysiological pathways.Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective seriesImmunohistochemical characterization of brain-invasive meningiomasDNA methylation in the malignant transformation of meningiomas.Molecular Targets and Treatment of Meningioma.Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.Application of CUSA Excel ultrasonic aspiration system in resection of skull base meningiomas.The mTOR signaling pathway as a treatment target for intracranial neoplasmsDural-based metastatic carcinomas mimicking primary CNS neoplasia: report of 7 cases emphasizing the role of timely surgery and accurate pathologic evaluationMolecular biological determinations of meningioma progression and recurrence.Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice.Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers.DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.Ligation-anchored PCR unveils immune repertoire of TCR-beta from whole blood.Genetic/molecular alterations of meningiomas and the signaling pathways targeted.Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.Systematic Analysis of Outcomes for Surgical Resection and Radiotherapy in Patients with Papillary Meningioma.The histopathological spectrum of human meningiomasPathology and molecular genetics of meningioma: recent advances.Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.Intracranial meningioma with ophthalmoplegia in a rhesus macaque (Macaca mulatta).Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.Predictors of recurrence in the management of chordoid meningiomaAlterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumorsClinicopathological analysis of metaplastic meningioma: report of 15 cases in Huashan HospitalPerfusion computed tomography of intracranial meningiomas: In vivo correlation of cerebral blood volume and vascular permeabilityPhase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningiomaTERT Promoter Mutations and Risk of Recurrence in Meningioma.CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas.
P2860
Q21146660-2D17F565-3825-495F-89E2-8E058C651457Q24307712-5A4910F0-7A5F-42E0-AFEC-67776071E1B9Q26739662-D1B8D8B2-A5BF-4B68-A20A-AC8100BB6CF3Q26820849-87AA5FE8-D611-4003-B246-428395773A27Q27853347-0469D3B6-0F7F-4CE3-8CC8-E09E600FB499Q28943376-8CFB15E3-D695-4BE9-A9ED-929A382B30CEQ30368396-A3CCA7CE-468A-4A41-B35F-9584F6B3B248Q30912220-3FFF43E4-6865-4F60-B9B5-11DAEC5D7B5FQ33785024-C1F4A25E-B9E1-4E46-BD4C-4EADC52410FFQ33790175-0560329D-F41D-4865-A97A-E9D6121AAB15Q34233236-42D05FB2-A65E-47E8-BD9E-65B36B45D9AAQ34246609-B413F08C-AADD-46F7-97F7-A0A69013947BQ34501813-C9CC63DC-B692-4065-93CB-B2261644C924Q34562612-A28DD81D-5D8F-4753-8F2E-F9BDB452C188Q34631513-1A072A84-B3FA-47C9-80A4-2F2FDA9F2165Q34716061-6C4DEB67-A1A8-480D-8654-2DE14095E488Q34785965-4F876102-FB5D-4FFC-BF98-9A079CFDA50BQ34886859-4FACFD19-E5AE-4EF1-B0D9-98F1F23E092BQ35079099-53A7EEF4-AF6A-4381-B613-B497D191F5B0Q35145251-DB620895-0E3B-4835-ABFC-04996D596682Q35392459-59368C01-682E-4FDF-8BA8-BD7C2BE68C44Q35440783-E3685ACC-4C06-4885-B6B6-6FE727C08A3BQ35584376-2EA8A175-D4F7-4C0E-95B3-215F3DBDB2DAQ35644152-7F4C9284-65C1-4C2C-8871-C0FD3355B17DQ35793582-9DE1552C-4B5C-4BC3-96EA-99AC09DE890DQ35848234-909F8DC3-525E-476E-86D7-7B1FE525BBC1Q35894213-5087BF71-2B0A-4709-84F1-16024E243738Q35926564-80ECF250-38E4-4457-881D-BDA2BE5D38BEQ35943650-006763FD-C322-4EAE-A2BA-814B7E76A5DBQ35947699-B370CD2D-766F-4109-A43B-A78E078625BBQ36321407-661ED1AF-5538-42E7-B8FD-EA3559BD72EFQ36346636-0FCB19F1-31CB-4929-9C17-E51D0A571736Q36375359-7908C953-970F-4082-9261-9E5FCC476047Q36386374-F40200A8-281D-4BDC-AACD-B6FAA17B46FBQ36493804-34AF11DA-3F64-4332-B372-A086786D1043Q36563246-56AA5C14-CB44-42A4-9CD7-8AFB6971284FQ36590031-599053DB-61A8-46DF-BB28-9C09689527E9Q36740517-F12B0DEF-B267-41A8-8758-7EE3712DE11EQ36849156-129A2787-CBD1-4592-8514-880211290A33Q36883373-398714E4-3BCE-4A6E-BA01-4603335297B0
P2860
Pathological classification and molecular genetics of meningiomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathological classification and molecular genetics of meningiomas.
@en
Pathological classification and molecular genetics of meningiomas.
@nl
type
label
Pathological classification and molecular genetics of meningiomas.
@en
Pathological classification and molecular genetics of meningiomas.
@nl
prefLabel
Pathological classification and molecular genetics of meningiomas.
@en
Pathological classification and molecular genetics of meningiomas.
@nl
P1476
Pathological classification and molecular genetics of meningiomas
@en
P2093
Christian Mawrin
P2860
P2888
P304
P356
10.1007/S11060-010-0342-2
P50
P577
2010-09-01T00:00:00Z